New study reveals how tumor cells evade the immune system

It is comparatively easy to tell a cell’s state of health: On their surface, cells present fragments of almost all the proteins they contain inside.

Novel Anti-Inflammatory Flops for HFpEF, HFmrEF

CHICAGO — The novel myeloperoxidase (MPO) inhibitor mitiperstat failed to improve quality of life or functional capacity in heart failure with mid-range to preserved ejection

November 19, 2024

CureVac Announces Voting Results of General Meeting – Biotech Investments

Issuer: CureVac / Key word(s): AGM/EGM 19.06.2023 / 17:30 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Voting Results

June 20, 2023

Carolyn Bertozzi and Versant’s new biotech breaks cover with $94M to use protein degraders in ADCs

In the bustling world of antibody-drug conjugates, few biopharmas have revealed ambitions for combining antibodies with protein degraders, rather than chemo or other cytotoxic drugs.

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.